glp 1 agonist wegovy Wegovy® A potentially blinding condition is

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss

The oral version must be taken in a special way - it should be taken after fasting overnight, with a small amount of water (no more than half a cup)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

Andrew Stokes received a grant from the Robert Wood Johnson Foundation analyze the real-word effects of this new class of appetite-suppressing therapies, as well as inequities in access to these medications.

Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy